Jane Hollingsworth

Jane Holmes Hollingsworth was the founder of Auxilium Pharmaceuticals LLC, founded in 1999, serving as Secretary, Executive VP & General Counsel.
Ms. Hollingsworth was the founder of NuPathe, Inc., founded in 2005, serving as Chief Executive Officer & Independent Director from 2011 to 2012.
Ms. Hollingsworth is also the founder of Eliksa Therapeutics, Inc...
Current positions include Vice Chairman at Kimmel Center, Inc., Chairman at Breastcancer.org, Director at University City Science Center since 2010, Non-Executive Director at Dignity Sciences Ltd., Director at S1 BioPharma, Inc. since 2014, Non-Executive Director at Afimmune Ltd., Director at RiboNova, Inc., Independent Director at CervoMed, Inc. since 2023, and Managing Partner at Militia Hill Ventures LLC since 2013.
Former positions include Chief Executive Officer at Immunome, Inc., Executive Chairman at Spirovant Sciences, Inc., Independent Director at Diffusion Pharmaceuticals, Inc. from 2020 to 2021, Secretary, Vice President & General Counsel at IBAH, Inc., and Attorney at Montgomery McCracken Walker & Rhoads LLP.
Education includes undergraduate studies at Gettysburg College and graduate studies at Villanova University.